Synedica Semaglutide 8mg Research Formulations
Welcome to the official catalog page for Synedica Semaglutide 8mg. Semaglutide is a landmark, highly selective Glucagon-Like Peptide-1 (GLP-1) receptor agonist engineered for metabolic, glycemic control, and obesity research studies.
Known internationally as semaglutida Synedica in Portuguese-speaking markets, our 8mg concentration provides an optimal, long-lasting vial capacity for extended multi-week research protocols.
Product Specifications & Overview
| Technical Parameter | Specification Standard |
| Product Name | Synedica Semaglutide 8mg |
| Active Compound | Semaglutide (GLP-1 Receptor Agonist) |
| CAS Registry Number | 910463-68-2 |
| Total Vial Yield | 8mg High-Purity Mass |
| Sequence Alignment | 31-amino acid human GLP-1 peptide analogue |
| Purity Threshold | $\ge 99.1\%$ HPLC Verified |
| Available Formats | Lyophilized Powder Vial / Pre-filled Caneta Synedica System |
Targeted Mechanism of Action: GLP-1 Selective Agonism
While multi-agonist compounds like Synedica Retatrutide and Synedica Tirzepatide target two or three receptor pathways, Synedica Semaglutide 8mg provides pure, targeted single-receptor GLP-1 agonism.
┌─────────────────────────┐
│ Synedica Semaglutide │
│ 8mg Formulation │
└────────────┬────────────┘
│
┌─────────────────────────┴─────────────────────────┐
▼ ▼
┌─────────────────────────┐ ┌─────────────────────────┐
│ Glucose-Dependent │ │ Central Satiety & │
│ Insulin Secretion │ │ Gastric Delay │
├─────────────────────────┤ ├─────────────────────────┤
│ • Stimulates pancreatic │ │ • Delays gastric │
│ beta-cell pathways │ │ emptying rate │
│ • Suppresses glucagon │ │ • Activates hypothalamic│
│ hyper-secretion │ │ satiety centers │
└─────────────────────────┘ └─────────────────────────┘
Why Choose the 8mg Concentration?
-
Extended Protocol Efficiency: The 8mg yield provides an ideal volume for multi-week escalating dose protocols without the need for frequent vial changes.
-
Superior Chemical Stability: Synthetic amino acid modifications (including a C-18 fatty diacid chain) provide extended plasma half-life stability compared to native GLP-1.
-
UK Lab Verification: Every 8mg vial undergoes HPLC and Mass Spectrometry testing in United Kingdom facilities to guarantee zero heavy metal or endotoxin contamination.
Available Formats: Vial or Caneta Synedica
-
Lyophilized Powder Vial (8mg): Vacuum-sealed freeze-dried powder designed for custom laboratory reconstitution using bacteriostatic water.
-
Semaglutide 8mg Auto-Pen (Caneta Semaglutida Synedica): Pre-calibrated liquid delivery device for precise, click-dial volumetric administration in animal or cellular trial designs.
Shipping & Logistics (UK & Brazil Focus)
-
United Kingdom Hub: Orders are processed and dispatched directly from our UK warehouse with tracked express courier options (
synedica labs onde fica). -
Dedicated Brazil Logistics: We provide safe, discreet international shipping to Brazil (envio seguro de semaglutida para o Brasil), using insulated packaging to shield peptide integrity against thermal fluctuations during air freight.
Frequently Asked Questions
What is the difference between Semaglutide 8mg and Tirzepatide?
Semaglutide is a selective mono-agonist targeting only the GLP-1 receptor, whereas Synedica Tirzepatide is a dual agonist targeting both GIP and GLP-1 receptors.
Reviews
There are no reviews yet.